Valion Bio share price logo

Valion Bio

NASDAQ: VBIO

$2.10

-0.16

(-7.08%)

as on

Valion Bio Stock Performance

as on September 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.16
    $2.42
    downward going graph

    -2.86%

    Downside

    15.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Valion Bio share price movements today

Previous Close
$2.26
Open
$2.22
Volume
466.2K
Market Cap
$2.0M
Day's Low - High
$2.16 - $2.42

Valion Bio Historical Returns

1 Month Return
-55.93 %
3 Month Return
-84.97 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Valion Bio Stock Fundamentals & Key Indicators

Check Valion Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0M

EPS (TTM)

-56.74

Dividend Yield

0.00%

PE Ratio (TTM)

-0.04

Industry PE ratio

-1.78

PEG Ratio

0.00002661192159670003

Return On Equity TTM

-165.44%

Valion Bio Stock Valuation

Track how Valion Bio P/E has moved over time to understand its valuation trends.

Valion Bio in the last 5 years

  • Overview

  • Trends

Lowest (-27.13x)

March 31, 2022

Today (-4.62x)

December 31, 2025

Industry (-1.78x)

December 31, 2025

Highest (-0.05x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -4.62x

Valion Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Valion Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$2.0MNA-0.04516.03%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Indian Investors' Interest in Valion Bio Stock

Search interest for Valion Bio Stock has increased by 81% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:81% versus previous 30 day period

Valion Bio Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
-
0
0
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-2
-2
-1
-1
-1
-1
-1
-1
-5
-6
EBITDA
-2
-2
-1
-1
-1
-1
-1
-1
-5
-6
Interest Expense
-
-
-
-
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-1
-1
-1
-1
-1
-1
-6
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-1
-1
-1
-1
-1
-2
-6
-7
Net Profit Margin
0.84%
50.00%
21.43%
-132.78%
0.00%
62.79%
-99.32%
100.00%
0.00%
0.00%

Valion Bio Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Dec 2019
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
-
0
0
1
1
-
-
Gross Profit
0
0
-
0
0
0
0
0
-
Operating Income
-3
-4
-4
-3
-3
-5
-10
-4
-7
EBITDA
-5
-4
-4
-3
-3
-5
-9
-4
-7
Interest Expense
0
-
0
0
0
1
-
-
0
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-5
-4
-4
-4
-3
-8
-10
-4
-7
Income Tax Expense
-
-
0
0
-
-
-
-
-
Net Income
-5
-4
-20
-4
-3
-8
-10
-5
-8
Net Profit Margin
33.73%
23.90%
-68.81%
-26.16%
-11.06%
16.25%
24.40%
8.38%
0.00%

Valion Bio Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-1
-1
-1
-1
-1
-1
-6
-7
Operating Cash Flow
-2
-2
-1
-1
0
-1
-1
-2
-5
-5
Investing Cash Flow
0
0
-
-
0
-
-
0
0
0
Financing Cash Flow
4
0
4
0
0
0
1
11
0
0
Change in Cash
1
-2
2
-1
-1
-1
0
9
-5
-5

Valion Bio Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Dec 2019
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-4
-20
-4
-3
-8
-10
-4
-7
Operating Cash Flow
-1
-2
-3
-3
-3
-5
-8
-5
-6
Investing Cash Flow
-
-
0
0
-
-
0
-
0
Financing Cash Flow
2
2
8
5
1
17
0
4
18
Change in Cash
1
0
5
2
-1
11
-9
-1
10

Mutual Funds that own Valion Bio Stock

Check out the Mutual Funds with significant holdings in Valion Bio.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
1.279532%
11357

Global Institutional Holdings in Valion Bio

Funds
Holdings
XTX Topco Ltd
0.33%
UBS Group AG
0.08%
Susquehanna International Group, LLP
0%
Citigroup Inc
0%
Geode Capital Management, LLC
2.8%

Insights on Valion Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, -302.0K → 1.10M (in $), with an average increase of 75.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 545.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 28.0% return, outperforming this stock by 122.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 9 quarters, -1.26M → -7.10M (in $), with an average decrease of 27.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VBIO stock has moved down by -16.0%

About Valion Bio

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
OrganisationValion Bio
Headquarters1305 E. Houston Street, San Antonio, TX, United States, 78205
IndustryBiotechnology
CEOMs. Lisa G. Wolf
E-voting on sharesClick here to vote

Key Management of Valion Bio

Name

Title

Ms. Lisa G. Wolf

President, CFO & COO

Ms. Melinda Lackey

General Counsel & Senior Vice President of Legal Affairs

FAQs

What is Valion Bio share price today?

Valion Bio share price today is $2.10 as on at the close of the market. Valion Bio share today touched a day high of $2.42 and a low of $2.16.

What is the 52 week high and 52 week low for Valion Bio share?

Valion Bio share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Valion Bio stock price today i.e. is closed at $2.10,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Valion Bio's market capitalisation today?

Valion Bio market capitalisation is $0.00T as on .

How to invest in Valion Bio Stock (VBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Valion Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Valion Bio Shares that will get you 0.7143 shares as per Valion Bio share price of $2.10 per share as on September 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Valion Bio Stock (VBIO) from India?

Indian investors can start investing in Valion Bio (VBIO) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Valion Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Valion Bio share’s latest price of $2.10 as on September 15, 2026 at 8:46 am IST, you will get 4.7619 shares of Valion Bio. Learn more about fractional shares .